Literature DB >> 19363706

Restoration of cardiac function by an iron chelator, deferasirox, in a patient with aplastic anemia and cardiac iron overload.

Toru Kiguchi1, Yoshikazu Ito1, Yukihiko Kimura1, Kazuma Ohyashiki2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19363706     DOI： 10.1007/s12185-009-0310-9

Source DB:  PubMed          Journal:  Int J Hematol        ISSN： 0925-5710            Impact factor:   2.490


× No keyword cloud information.
  12 in total

1.  Non-invasive cardiac evaluation in heart failure patients using magnetic resonance imaging: a feasibility study.

Authors:  Stephanie M Shors; William G Cotts; Biljana Pavlovic-Surjancev; Mihai Gheorghiade; James C Carr; Richard M McCarthy; Scott F Pereles; Paul J Finn
Journal:  Heart Fail Rev       Date:  2005-12       Impact factor: 4.214

2.  Deferasirox and deferiprone remove cardiac iron in the iron-overloaded gerbil.

Authors:  John C Wood; Maya Otto-Duessel; Ignacio Gonzalez; Michelle I Aguilar; Hiro Shimada; Hanspeter Nick; Marvin Nelson; Rex Moats
Journal:  Transl Res       Date:  2006-11       Impact factor: 7.012

3.  Efficacy of deferoxamine in preventing complications of iron overload in patients with thalassemia major.

Authors:  G M Brittenham; P M Griffith; A W Nienhuis; C E McLaren; N S Young; E E Tucker; C J Allen; D E Farrell; J W Harris
Journal:  N Engl J Med       Date:  1994-09-01       Impact factor: 91.245

Review 4.  Myelodysplastic syndromes: iron overload consequences and current chelating therapies.

Authors:  Peter L Greenberg
Journal:  J Natl Compr Canc Netw       Date:  2006-01       Impact factor: 11.908

Review 5.  Concepts and goals in the management of transfusional iron overload.

Authors:  John B Porter
Journal:  Am J Hematol       Date:  2007-12       Impact factor: 10.047

6.  Retrospective nationwide survey of Japanese patients with transfusion-dependent MDS and aplastic anemia highlights the negative impact of iron overload on morbidity/mortality.

Authors:  Masaaki Takatoku; Takashi Uchiyama; Shinichiro Okamoto; Yuzuru Kanakura; Kenichi Sawada; Masao Tomonaga; Shinji Nakao; Tatsutoshi Nakahata; Mine Harada; Takashi Murate; Keiya Ozawa
Journal:  Eur J Haematol       Date:  2007-03-28       Impact factor: 2.997

7.  Myocardial iron overload assessment by T2* magnetic resonance imaging in adult transfusion dependent patients with acquired anemias.

Authors:  Anna Angela Di Tucci; Gildo Matta; Simona Deplano; Attilio Gabbas; Cristina Depau; Daniele Derudas; Giovanni Caocci; Annalisa Agus; Emanuele Angelucci
Journal:  Haematologica       Date:  2008-07-04       Impact factor: 9.941

8.  Evaluation of cardiac iron overload in transfusion-dependent adult marrow failure patients by magnetic resonance imaging.

Authors:  Jinho Park; Kazuma Ohyashiki; Soichi Akata; Kenichi Takara; Ritsuko Uno; Dai Kakizaki; Keisuke Miyazawa; Yukihiko Kimura; Koichi Tokuuye
Journal:  Leuk Res       Date:  2008-11-26       Impact factor: 3.156

Review 9.  Japanese epidemiological survey with consensus statement on Japanese guidelines for treatment of iron overload in bone marrow failure syndromes.

Authors:  Takahiro Suzuki; Masao Tomonaga; Yasushi Miyazaki; Shinji Nakao; Kazuma Ohyashiki; Itaru Matsumura; Yutaka Kohgo; Yoshiro Niitsu; Seiji Kojima; Keiya Ozawa
Journal:  Int J Hematol       Date:  2008-06-27       Impact factor: 2.490

10.  A safety, pharmacokinetic and pharmacodynamic investigation of deferasirox (Exjade, ICL670) in patients with transfusion-dependent anemias and iron-overload: a Phase I study in Japan.

Authors:  Keisuke Miyazawa; Kazuma Ohyashiki; Akio Urabe; Tomoko Hata; Shinji Nakao; Keiya Ozawa; Takayuki Ishikawa; Junji Kato; Yoichi Tatsumi; Hiraku Mori; Midori Kondo; Junsuke Taniguchi; Hiromi Tanii; Lisa Rojkjaer; Mitsuhiro Omine
Journal:  Int J Hematol       Date:  2008-07-04       Impact factor: 2.319
View more
  2 in total

1.  Estimation of cardiac left ventricular ejection fraction in transfusional cardiac iron overload by R2* magnetic resonance.

Authors:  Juri Sakuta; Yoshikazu Ito; Yukihiko Kimura; Jinho Park; Koichi Tokuuye; Kazuma Ohyashiki
Journal:  Int J Hematol       Date:  2010-11-25       Impact factor: 2.490

2.  Management of transfusional iron overload - differential properties and efficacy of iron chelating agents.

Authors:  Janet L Kwiatkowski
Journal:  J Blood Med       Date:  2011-09-21
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.